Yacktman Asset Management LP lowered its stake in The Clorox Company (NYSE:CLX – Free Report) by 18.5% during the fourth quarter, HoldingsChannel reports. The institutional investor owned 48,095 shares of the company’s stock after selling 10,900 shares during the quarter. Yacktman Asset Management LP’s holdings in Clorox were worth $4,849,000 at the end of the most recent quarter.
Other large investors also recently bought and sold shares of the company. Center for Financial Planning Inc. acquired a new position in Clorox in the third quarter valued at about $25,000. Vermillion & White Wealth Management Group LLC acquired a new position in Clorox in the third quarter valued at about $25,000. Root Financial Partners LLC acquired a new position in Clorox in the third quarter valued at about $29,000. Darwin Wealth Management LLC acquired a new position in Clorox in the second quarter valued at about $29,000. Finally, Vision Financial Markets LLC increased its stake in Clorox by 166.7% during the fourth quarter. Vision Financial Markets LLC now owns 320 shares of the company’s stock worth $32,000 after purchasing an additional 200 shares during the period. Institutional investors and hedge funds own 78.53% of the company’s stock.
Key Stories Impacting Clorox
Here are the key news stories impacting Clorox this week:
- Positive Sentiment: Unusual options activity showed strong bullish speculation, with traders buying 14,071 CLX call options on Friday, far above the typical daily volume. This may signal expectations for a rebound.
- Positive Sentiment: Several articles highlighted Clorox as a high-yield dividend stock, noting its roughly 5.7% yield and its potential to become a Dividend King in 2027 if it continues raising payouts.
- Positive Sentiment: A director reportedly bought about $429,100 worth of Clorox shares, which investors often view as a sign of insider confidence.
- Neutral Sentiment: Long-term performance commentary emphasized Clorox’s consistency as a consumer staples company, with steady dividends and resilience over the past decade, but without a clear new catalyst for near-term earnings. If You Had Invested $1,000 in Clorox a Decade Ago: A Prospective Dividend King’s Long-Term Payoff
- Negative Sentiment: Pomerantz LLP said it is investigating claims on behalf of Clorox investors, adding legal uncertainty that could weigh on the stock. INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of The Clorox Company – CLX
- Negative Sentiment: Commentary noted that Clorox has fallen to an 11-year low, reflecting weaker investor confidence despite its dividend yield. Contrarian Take: This High-Yield Dividend Stock Is a Buy in May Despite Falling to an 11-Year Low
Clorox Stock Down 0.1%
Clorox (NYSE:CLX – Get Free Report) last released its earnings results on Thursday, April 30th. The company reported $1.64 earnings per share for the quarter, topping analysts’ consensus estimates of $1.55 by $0.09. Clorox had a net margin of 11.18% and a return on equity of 443.64%. The firm had revenue of $1.67 billion for the quarter, compared to analyst estimates of $1.67 billion. During the same period in the prior year, the firm earned $1.45 earnings per share. The business’s quarterly revenue was up .1% compared to the same quarter last year. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. Analysts predict that The Clorox Company will post 5.63 EPS for the current year.
Clorox Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Friday, May 8th. Investors of record on Wednesday, April 22nd were paid a dividend of $1.24 per share. This represents a $4.96 dividend on an annualized basis and a dividend yield of 5.4%. The ex-dividend date was Wednesday, April 22nd. Clorox’s dividend payout ratio is presently 80.52%.
Insider Buying and Selling at Clorox
In other news, Director Pierre R. Breber bought 5,000 shares of the business’s stock in a transaction that occurred on Tuesday, May 5th. The shares were purchased at an average cost of $85.82 per share, for a total transaction of $429,100.00. Following the completion of the purchase, the director owned 18,000 shares of the company’s stock, valued at approximately $1,544,760. This represents a 38.46% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 0.63% of the company’s stock.
Analyst Ratings Changes
A number of brokerages have issued reports on CLX. TD Cowen boosted their price target on shares of Clorox from $98.00 to $111.00 and gave the stock a “hold” rating in a research note on Tuesday, March 31st. Wells Fargo & Company cut their price target on shares of Clorox from $110.00 to $100.00 and set an “equal weight” rating on the stock in a research note on Friday, May 1st. Evercore reiterated an “underperform” rating and set a $110.00 price target on shares of Clorox in a research note on Friday, May 1st. Wall Street Zen upgraded shares of Clorox from a “sell” rating to a “hold” rating in a research note on Saturday, February 7th. Finally, Deutsche Bank Aktiengesellschaft reiterated a “hold” rating and set a $91.00 price target on shares of Clorox in a research note on Friday, May 1st. One research analyst has rated the stock with a Buy rating, twelve have issued a Hold rating and four have given a Sell rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Reduce” and a consensus price target of $104.00.
Read Our Latest Report on Clorox
Clorox Profile
The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.
Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.
Featured Stories
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.
